Borosil Scientific Ltd has been a prominent player in the field of high-quality scientific and laboratory glassware since 1962, serving critical applications in pharmaceutical quality control, food and soil testing, microbiology, and biotechnology. The company was established as a distinct entity through a demerger process from Borosil Ltd, with Borosil Scientific Limited (BSL) subsequently listed on the exchange on June 24, 2024. Borosil Scientific is an integral part of the broader Borosil group, which encompasses various specialized companies including Borosil Renewables Ltd and Borosil Ltd. Collectively, the group is involved in diverse sectors such as glassware and laboratory products, scientific & industrial glassware, consumer & kitchenware products, and solar glass.
The company operates through two main business segments, offering a wide array of products. Borosil Scientific is engaged in the manufacturing and trading of Scientific & Industrial Products (SIP) and the manufacturing of Consumer Products (CP). The SIP segment includes laboratory glassware, scientific instruments, disposable plastics, liquid handling systems, explosion-proof lighting glassware, glass ampoules, tubular glass vials, and pharmaceutical packaging. The CP segment comprises items like glass tumblers, glass bottles, and storage products.
The company's laboratory equipment range is marketed under the Labquest brand, ensuring compliance with both national and international standards. Borosil Scientific also specializes in the production of Glass Ampoules and Tubular Glass Vials made from USP Type 1 glass, which are essential primary packaging materials for life-saving injectable pharmaceuticals. Its portfolio is further enhanced by Analytical Vials.
Following the acquisition of Goel Scientific Glass Works Limited in April 2023, the company expanded its Process Sciences division, now offering sophisticated solutions for chemical synthesis, research process development, and industrial chemical processing equipment.
Borosil Scientific commenced its business operations at the Ambad Factory in Nashik in 1994, and later established operations at the Gonde Factory in Igatpuri in 2012. These facilities represent the company's strategic expansion to enhance manufacturing capabilities and effectively serve diverse market segments.
As of recent market data, the company's market capitalization stands at approximately ₹1,233 Crore. (Note: A specific mention of ₹1,446 crore and ₹1,198.11 Cr as of July 2025 was present, indicating fluctuation or different reporting dates. The ₹1,233 Cr figure aligns with the peer comparison).
The company's financial performance indicates mixed recent results. For the full year ended March 2025, net profit increased by 13.75% to ₹26.80 crore, up from ₹23.56 crore in the previous year. Revenue for the same period rose by 10.74% to ₹438.49 crore, compared to ₹395.98 crore in the year ended March 2024.
However, quarterly performance has shown some challenges. For the quarter ended March 2025, net profit saw a decline of 6.67% to ₹8.67 crore, down from ₹9.29 crore in the corresponding quarter of the previous year. Sales for the quarter ended March 2025 increased by 11.90% to ₹129.48 crore, compared to ₹115.71 crore in the quarter ended March 2024.
The most recent quarterly results indicate continued pressure on profitability. Borosil Scientific Ltd's revenue grew by 2.55% year-on-year to ₹103.31 Crore in Q3 FY2024-2025. However, net profit fell by -25.09% year-on-year to ₹4.30 Crore during the same period. The earnings per share (EPS) for Borosil Scientific Ltd stood at ₹0.5 during Q3 FY25.
- Revenue: ₹438 Crore (FY25)
- Net Profit: ₹26.7 Crore (FY25)
- Stock Valuation: Trading at 3.57 times its book value.
- Promoter Holding: 67.8%
- Debt Status: The company is almost debt-free.
The company has recently implemented several strategic initiatives. A Voluntary Retirement Scheme (VRS) was completed at the Ambad Plant, with a payout of ₹647.54 Lakhs to eligible workers. Borosil Scientific also granted 14,08,100 stock options under its Employee Stock Option Scheme (ESOS) on February 11, 2025.
Borosil Scientific's primary competitors include Arrow Greentech, Oricon Enterprises, Pyramid Technoplast, Creative Graphic Sol, Rajeshwari Cans, GSM Foils, and Kaira Can Co. With a market capitalization of ₹1,233 Crore, Borosil Scientific is larger than the median market cap of its peers, which is ₹395 Crore. Based on its financial stability, Borosil Scientific appears to be in a stronger position compared to many of its competitors.
The stock has experienced volatility in recent periods. The Borosil Scientific Ltd (BOROSCI) share price is ₹139.42, which is down -39.38% from its 52-week high of ₹230. The Borosil Scientific share reached a 1-year low of ₹107.42 and a 1-year high of ₹230.
While the company has consistently reported profits, it has not paid out dividends. Borosil Scientific's financial stability and debt-free status provide a solid foundation for growth. However, recent quarterly performance suggests challenges in maintaining profit margins, likely due to competitive pressures within the scientific glassware industry.
